CHCT Bets on Retention: Dividend Cut Fuels a New Growth Playbook
Healthcare REIT slashes payout to fund acquisitions and drive occupancy, betting that disciplined capital recycling can finally turn around a long slide.
CHCT · Earnings Call · 2026-08-05
A Pivot Long in the Making
Community Healthcare Trust (CHCT) reported second-quarter 2026 results that landed with an unusual jolt for a small-cap healthcare REIT. The company announced a dividend rightsizing—cutting its quarterly dividend from $0.48 to $0.33 per share—as the centerpiece of a new strategic plan. CEO Dave Dupuy framed it not as a concession but as an offensive move:
First, we are right-sizing our quarterly dividend from $0.48 to $0.33 per share. This decision allows us to retain capital directly for accretive acquisitions and long-term portfolio growth.
For a REIT, dividends are sacrosanct, and the cut signals a willingness to reset shareholder expectations in pursuit of growth. The rationale is clear: with the stock price down from its 2021 peak and the cost of equity prohibitive, CHCT has been forced to fund acquisitions through asset sales and retained cash flow. As CFO Bill Monroe explained, the dividend reduction frees up $25–30 million over two years, which on a leverage-neutral basis supports an incremental $25 million of acquisitions per year, translating to $0.06–$0.07 of AFFO growth annually. The company is targeting a 60–65% AFFO payout ratio going forward, a shift from the prior quarterly increases.
Occupancy: The First Priority
Management’s plan rests on four strategic pillars, starting with occupancy improvement. CHCT had struggled with elevated lease expirations in 2025 and 2026, but leadership now sees a clear path to 92% occupancy by end-2027. The company signed over 100,000 square feet of new leases year-to-date, already exceeding 2025 totals, and the leasing activity is broad-based. Dupuy was direct about the timeline: “I think the timeframe, we feel like we can get to that 92% as early as at the end of 2027.” — David Dupuy, Chief Executive Officer · 2026-08-05 He added that the portfolio’s full occupancy is likely 92–93%, given the mix of medical office properties, so this is not a stretch goal but a return to normalcy.
The occupancy tailwind is amplified by a structural improvement in expirations. The big expirations were front-loaded, as Dupuy noted: “So we had big years. I think it was north of 10% each -- in each of 2025 and 2026.” — David Dupuy, Chief Executive Officer · 2026-08-05 With those behind, the company can finally focus on proactive leasing rather than firefighting renewals.
Capital Recycling and Redevelopment
The second and third priorities—portfolio reinvestment and capital recycling—are designed to upgrade the property base. CHCT has sold 7 properties since 2025, generating $38.5 million in net proceeds, with another $70 million in assets on the market. These dispositions fund a pipeline of acquisitions and redevelopment projects, which offer 9–12% yields on cost. The company is also building speculative suites in high-demand markets, a feature that has shown promise.
This is not a new theme—management has talked about capital recycling for over a year—but the emphasis has shifted. In the prior quarter, Dupuy framed it as a necessity given the stock price: “What we are doing in terms of focusing on capital recycling is using this as an opportunity to do two things. Obviously, we are using this as an opportunity to trim some of the properties that are in less attractive markets.” — David H. Dupuy, Chief Executive Officer · 2026-05-06 Now, it is part of a coordinated growth strategy, with dispositions matched to acquisitions to keep leverage modest. The company expects to close $85–90 million of acquisitions in 2026, with further acceleration in 2027.
Financial Backdrop and Leverage
The financial context is sobering. CHCT’s stock has been in a prolonged downtrend, with a 71.5% drawdown from its 2021 peak and a 21.8% drawdown just in the last 90 days. The company’s leverage has been creeping up: Liabilities to Assets reached 58.3% at the end of the latest quarter, up from 53% a year earlier. Interest coverage remains healthy at 2.9x, but the trend is one of rising debt to finance a portfolio that has not yet recovered its growth momentum. The dividend cut is a necessary step to offset this pressure without diluting shareholders at depressed prices.
While the company remains tied to the resolution of the geriatric behavioral hospital operator (now in late-stage sale process), the broader strategic pivot is a clear attempt to reassert control. As Dupuy repeatedly emphasized, the plan is to earn growth organically and through disciplined acquisitions. If occupancy gains materialize and the acquisition pipeline closes, CHCT could finally break the cycle of capital recycling without accretive growth. The market will be watching the third-quarter signing of the behavioral hospital transaction and the pace of new acquisitions with particular interest.